Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.32 |
| ▸ | PLA2G4A | P47712 | 1/20 | 0.32 |
| ▸ | ATM | Q13315 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | AHR | P35869 | 1/20 | 0.30 |
| ▸ | CHEK2 | O96017 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26507570 | 0.92 | AHR (0.32) | KDM4EMEN1NPC1ALDH1A1MAPT | |
| SCHEMBL16811434 | 0.91 | CHEK2 (0.32) | PLA2G2APLA2G4ACHEK2 | |
| SCHEMBL17246522 | 0.91 | SMN1; SMN2 (0.35) | KDM4EMEN1NPC1ALDH1A1MAPT | |
| SCHEMBL25775511 | 0.90 | MAPT (0.32) | KDM4EMEN1NPC1ALDH1A1MAPT | |
| SCHEMBL24923136 | 0.90 | PLA2G2A (0.33) | KDM4EPLA2G2APLA2G4AATML3MBTL1 | |
| SCHEMBL11987378 | 0.88 | KDM4E (0.36) | KDM4EMEN1NPC1ALDH1A1MAPT | |
| SCHEMBL24923138 | 0.87 | GPR3 (0.36) | KDM4EMEN1ALDH1A1MAPTHPGD | |
| SCHEMBL25775528 | 0.87 | PLA2G2A (0.32) | KDM4EPLA2G2APLA2G4AATML3MBTL1 | |
| SCHEMBL17705549 | 0.86 | SMN1; SMN2 (0.35) | KDM4EMEN1NPC1ALDH1A1MAPT | |
| SCHEMBL19830777 | 0.86 | KDM4E (0.31) | KDM4EPLA2G2APLA2G4AATML3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230033529-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO.,LTD. (JP) | 2023-02-02 | — | — | US | disclosed |
| US-20230027888-A1 | ORGANIC ELECTROLUMINESCENT DEVICE, ORGANIC ELECTROLUMINESCENCE DISPLAY DEVICE, ELECTRONIC DEVICE AND COMPOUND | IDEMITSU KOSAN CO.,LTD. (JP) | 2023-01-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230027888-A1 | ORGANIC ELECTROLUMINESCENT DEVICE, ORGANIC ELECTROLUMINESCENCE DISPLAY DEVICE, ELECTRONIC DEVICE AND COMPOUND | HTR1D, EHD1, HTR3D | KDM4E 3361/4885MEN1 451/4885NPC1 2193/4885 |
| US-20230033529-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC DEVICE | LEF1, L1CAM, RAP1A | KDM4E 3096/4885MEN1 1068/4885NPC1 4128/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.